Feb 19, 2013
By:
Stephanie Sutton
The European Medicines Agency?s Committee for Orphan Medicinal Products (COMP) is seeking to expand its international cooperation in 2013.
|
Feb 18, 2013
By:
Stephanie Sutton
Sanofi is investing EUR 44 million ($58.7 million) in Genzyme?s biotechnology campus in Waterford, Ireland.
|
Feb 12, 2013
By:
Stephanie Sutton
The biopharmaceutical company lycera has announced a collaboration agreement with Merck, Sharpe & Dohme (MSD) that will focus on developing and commercializing small-molecule therapies for treating a range of autoimmune diseases.
|
Feb 11, 2013
By:
Stephanie Sutton
An international consortium of pharmaceutical companies, academia, research organisations and other related entities have launched a new platform to help enhance drug discovery in Europe.
|
Feb 5, 2013
By:
Stephanie Sutton
GlaxoSmithKline has increased its stake in its Indian subsidiary, GlaxoSmithKline Consumer Healthcare Ltd, from 43.2% to 72.5%.
|
A round up of news from across the web, including trends from social social media platforms.
Feb 2, 2013
By:
Stephanie Sutton
A round up of news from across the web, including trends from social social media platforms.
|
|
Feb 1, 2013
By:
Stephanie Sutton
The European Commission claims that Johnson & Johnson and Novartis may have breached European antitrust rules.
|
Jan 28, 2013
By:
Stephanie Sutton
GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination pediatric vaccine to help protect children in India and other developing countries from certain infectious diseases.
|
Jan 25, 2013
By:
Stephanie Sutton
AstraZeneca and Ceram Research, a materials development company based in the UK, have signed an agreement whereby Ceram will develop its inorganic-based controlled release technology in a feasibility study for delivering select AstraZeneca compounds.
|
|
